Allez à nos transactions
TMT

Aimia has completed a valuation

Aimia has completed a valuation in connection with a substantial issuer bid, purchasing for cancellation CAD$150 million of shares.

Listed on the TSX, Aimia offers loyalty solutions for many of the world’s leading brands in the retail, consumer packaged goods, travel and hospitality, and financial services verticals.

Oaklins’ team in Canada was retained as a valuation expert by Aimia’s Audit Committee of the Board of Directors to provide an independent valuation in accordance with MI 61–101, and valued the common shares in the range of CAD$541–CAD$686 million.

Parties prenantes

Contacter l'équipe de la transaction

Sandy Rhind

Associé
Toronto, Canada
Oaklins Canada

Blair Agnew

Associé
Toronto, Canada
Oaklins Canada

Transactions connexes

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

En apprendre plus
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

En apprendre plus
Bayer AG has entered into a takeover agreement with Cara Care
Soins de la Santé | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

En apprendre plus